CP Pharmaceuticals
CP Pharma gets FDA warning for Wrexham facility
November 18, 2010Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing
UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
